Anthony N. Amato - 30 Apr 2024 Form 3 Insider Report for BioSig Technologies, Inc. (BSGM)

Role
Chief Executive Officer, Director
Signature
/s/ Anthony Amato
Issuer symbol
BSGM
Transactions as of
30 Apr 2024
Net transactions value
$0
Form type
3
Filing time
05 Jul 2024, 16:00:16 UTC
Next filing
13 Sep 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BSGM Common Stock, $0.001 par value per share 500,000 30 Apr 2024 Direct F1
holding BSGM Common Stock, $0.001 par value per share 50,000 30 Apr 2024 Direct F2
holding BSGM Common Stock, $0.001 par value per share 6,250 30 Apr 2024 Direct F3
holding BSGM Common Stock, $0.001 par value per share 1,952 30 Apr 2024 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of restricted stock were granted for services and were fully vested as of March 1, 2024, the date of the grant, based on a closing price of $0.705 per share.
F2 The shares of restricted stock were granted for services and were fully vested as of June 7, 2024, the date of the grant, based on a closing price of $1.865 per share.
F3 Consists of (i) 2,500 shares of restricted stock granted for services on January 5, 2021 with a cost basis of $39.90 that vested in equal quarterly installments over one year, and (ii) 3,750 shares of restricted stock units granted for services on June 26, 2023 with an average cost basis of $5.05 that vested in two equal quarterly installments.
F4 The shares of common stock were purchased in a private placement on March 12, 2019, based on a price of $40.00 per share.

Remarks:

Mr. Amato was appointed as chief executive officer of BioSig Technologies, Inc. on April 30, 2024.